Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen

Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen

There is an ongoing debate regarding whether low-level viremia (LLV), in particular persistent LLV, during HIV treatment with optimal adherence originates from low-level viral replication, viral production, or both. We performed an observational study in 30 individuals with LLV who switched to a boo...

Full description

Bibliographic Details
Main Authors:	Arjen J. Stam, Ninée V. E. J. Buchholtz, Wouter F. W. Bierman, Reinout van Crevel, Andy I. M. Hoepelman, Mark A. A. Claassen, Heidi S. M. Ammerlaan, Berend J. van Welzen, Marjo E. E. van Kasteren, Steven F. L. van Lelyveld, Dorien de Jong, Kiki Tesselaar, Matthijs van Luin, Monique Nijhuis, Annemarie M. J. Wensing, LOWERIT Study Team
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Viruses
Subjects:	HIV-1 low-level viremia immune activation HIV pathogenesis replication production
Online Access:	https://www.mdpi.com/1999-4915/16/2/182

Similar Items

Clonal Expansion of Infected CD4+ T Cells in People Living with HIV
by: John M. Coffin, et al.
Published: (2021-10-01)

Platelet-HIV: interactions and their implications
by: Sidney W. Whiteheart
Published: (2022-02-01)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
by: Jana L. Jacobs, et al.
Published: (2019-10-01)

Immune escape mutations in HIV-1 controllers in the Brazilian Amazon region
by: Samara Tatielle Monteiro Gomes, et al.
Published: (2020-07-01)

Use of darunavir in HIV-infected women during pregnancy
by: L Iu Afonina, et al.
Published: (2013-11-01)

Population prevalence of antiretroviral therapy sharing and its association with HIV viremia in rural Uganda: a cross‐sectional population‐based study
by: Caitlin E. Kennedy, et al.
Published: (2023-09-01)

Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs
by: Gilles Darcis, et al.
Published: (2020-04-01)

Facilitators and barriers to status disclosure and partner testing of women living with HIV in Indonesia: a mixed methods study
by: Annisa Rahmalia, et al.
Published: (2022-12-01)

Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection
by: Emil Johansson, et al.
Published: (2022-10-01)

Characterization of low level viraemia in HIV-infected patients receiving boosted protease inhibitor-based antiretroviral regimens
by: Francesca Ferretti, et al.
Published: (2019-09-01)

Low-level viraemia despite emergence of dolutegravir-resistant variants
by: Johannes C. Botha, et al.
Published: (2022-09-01)

Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy
by: Melissa A. Tosiano, et al.
Published: (2022-12-01)

Persistent Low-Level Viremia is an Independent Risk Factor for Virologic Failure: A Retrospective Cohort Study in China
by: Li Q, et al.
Published: (2021-11-01)

Unique Flap Conformation in an HIV-1 Protease with High-level Darunavir Resistance
by: Masaaki eNakashima, et al.
Published: (2016-02-01)

Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort
by: Kairi Pullerits, et al.
Published: (2022-10-01)

The Role of Mental Health Conditions in the Diagnosis of Neurocognitive Impairment in People Living with HIV
by: Irene Portilla-Tamarit, et al.
Published: (2020-07-01)

Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China
by: Pengtao Liu, et al.
Published: (2022-05-01)

Multifaceted impact of host C-C chemokine CCL2 in the immuno-pathogensis of HIV-1/ M tuberculosis co-infection
by: A Wahid Ansari, et al.
Published: (2013-10-01)

The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ Ratios
by: Victor Sanchez-Merino, et al.
Published: (2023-12-01)

Antiretroviral Treatment-Induced Galectin-9 Might Impact HIV Viremia in Addition to Contributing to Inflammaging
by: Ashwini Shete, et al.
Published: (2023-07-01)

Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors
by: Varsha M. Prabhu, et al.
Published: (2019-12-01)

HIV-1 Drug Resistance Profiles of Low-Level Viremia Patients and Factors Associated With the Treatment Effect of ART-Treated Patients: A Cross-Sectional Study in Jiangsu, China
by: Defu Yuan, et al.
Published: (2022-07-01)

Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study
by: Xiaojie Lao, et al.
Published: (2024-01-01)

Interferon Alpha-Inducible Protein 27 Expression Is Linked to Disease Severity in Chronic Infection of Both HIV-1 and HIV-2
by: Angelica A. Palm, et al.
Published: (2022-06-01)

A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?
by: Berend J. van Welzen, et al.
Published: (2019-01-01)

Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype
by: Pierluigi Francesco Salvo, et al.
Published: (2023-03-01)

Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia
by: Jusuf Hadi, et al.
Published: (2011-08-01)

Researching of resistance to etravirine in some HIV-1 low-level viremia strains by in-silico methods
by: Oflaz Ofcan, et al.
Published: (2023-08-01)

CCR5∆32 and SDF1 3′A: Gene Variants, Expression and Influence on Biological Markers for the Clinical Progression to AIDS among HIV-1 Virus Controllers in a Mixed Population of the Amazon Region of Brazil
by: Érica Ribeiro Gomes Lima, et al.
Published: (2023-03-01)

Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis
by: Keith Dunn, et al.
Published: (2021-07-01)

Facial botryomycosis-like pyoderma in an HIV-infected patient: remission after initiation of darunavir and raltegravir
by: Walter de Araujo Eyer-Silva, et al.

Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis
by: Anita Mesic, et al.
Published: (2021-04-01)

Decentralization of viral load testing to improve HIV care and treatment cascade in rural Tanzania: observational study from the Kilombero and Ulanga Antiretroviral Cohort
by: Dorcas Mnzava, et al.
Published: (2023-04-01)

HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in China
by: Li Q, et al.
Published: (2022-11-01)

Factors Associated with the Size of HIV DNA Reservoir
by: Ni-Dan Wang, et al.
Published: (2017-01-01)

Hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis, cytomegalovirus viremia, and nontuberculous mycobacteria bacteremia in a patient with recently diagnosed AIDS
by: Benjamin Fogelson, et al.
Published: (2022-01-01)

A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine
by: Mariana Pereira, et al.
Published: (2023-10-01)

Correlation of clinical illness with viremia in Zika virus disease during an outbreak in Singapore
by: Ng, Deborah H. L., et al.
Published: (2018)

Clinical experience with dolutegravir: efficacy, safety, and tolerability
by: Isabel Furtado, et al.
Published: (2022-01-01)

Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care
by: Dominique Van Beckhoven, et al.
Published: (2022-12-01)